title: Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study.
authors.forename: Ioannis S
authors.initials: IS
authors.lastname: Elefsiniotis
authors.forename: Nikolaos V
authors.initials: NV
authors.lastname: Fotos
authors.forename: Konstantinos D
authors.initials: KD
authors.lastname: Pantazis
authors.forename: Despina
authors.initials: D
authors.lastname: Papadeli
authors.forename: Christos
authors.initials: C
authors.lastname: Mavrogiannis
mesh_terms: D000328:Adult; D000906:Antibodies / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D002446:Celiac Disease / Q000150:complications*; D005260:Female; D005903:Gliadin / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011446:Prospective Studies; D012254:Ribavirin / Q000627:therapeutic use*; D011503:Transglutaminases / Q000276:immunology
chemical_list: D000906:Antibodies; D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin; D005903:Gliadin; D011503:Transglutaminases